Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FH5AX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,245
Award facts
- Contract value 100% obligated
- $34,244.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,244.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, represents a specific fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, which carries a $500 million ceiling value through November 2026. No set-aside designation was applied to this particular award, allowing the contractor to compete on an unrestricted basis.
DMS Pharmaceutical Group leverages its established position as a critical supplier within the federal pharmaceutical supply chain to fulfill medical supply requirements for Department of Defense healthcare facilities. The company's contract portfolio demonstrates consistent success in securing delivery orders for a diverse range of pharmaceutical products, including biologics, auto-injectors, specialty medications, and medical consumables. This delivery order for Xolair, a biologic treatment product, exemplifies the contractor's role in supporting military health system needs across locations nationwide, with performance to be executed at the company's facility in Park Ridge, Illinois.
Quick answers
Who was awarded contract SPE2DB25FH5AX?
SPE2DB25FH5AX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FH5AX worth?
The government has obligated $34,245 on SPE2DB25FH5AX.
Is contract SPE2DB25FH5AX an order under another contract?
Yes. SPE2DB25FH5AX is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5AX competed?
The extent of competition for SPE2DB25FH5AX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award